Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216319 · ClinicalTrials.gov registry record · NA
Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01216319 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 50 participants.
The verdict
NCT01216319, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Patients with a desire for nipple reconstruction following breast cancer and breast reconstruction will receive a surgical procedure to reconstruct one or both nipples utilizing the COOK Biodesign® Nipple Reconstruction Cylinder.
Interventions
- DEVICE Nipple reconstruction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216319
The ClinicalTrials.gov registry entry for NCT01216319 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nipple reconstruction is the first listed.
NCT01216319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01216319 about?
NCT01216319 is a clinical study titled "Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)". Patients with a desire for nipple reconstruction following breast cancer and breast reconstruction will receive a surgical procedure to reconstruct one or both nipples utilizing the COOK Biodesign® Nipple Reconstruction Cylinder.
What is the current status of trial NCT01216319?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01216319?
The interventions under investigation include: Nipple reconstruction (DEVICE).
Who is sponsoring clinical trial NCT01216319?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.